Common Stock SEC Reporting - Current
Pink Current Information
Contact Info
  • 4509 S. 143rd Street
  • Suite 1
  • Omaha, NE 68137

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001374328
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Michael Abrams Interim CFO
John S. Wilson President, CEO
Warren Rothouse IR
Company Directors
Michael Abrams
Lewis Jaffe
Todd Ordal
John S. Wilson
Seth Yakatan
Service Providers
Accounting/Auditing Firm
Tarvaran Askelson & Company, LLP
35565 B Golden Lantern
Suite 509
Dana Point, CA, 92629
United States
Securities Counsel

Not Available
Investor Relations Firm
Network 1 Financial Securities
The Galleria Building, 2 Bridge Avenue
4th Floor
Red Bank, NJ, 07701
United States
Company History
  • Formerly=Bond Laboratories, Inc. until 9-2013
FTLF Security Details
Share Structure
Market Value1 $6,375,089 a/o Mar 24, 2017
Authorized Shares Not Available
Outstanding Shares 10,450,965 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.01
Transfer Agent(s)
Shareholders of Record Not Available
Short Selling Data
Short Interest 6,731 (235.71%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security